Nicole Schlautmann is the Rare Disease Lead at Pfizer in Germany.
In her career she has worked extensively in the fields of Rare Diseases and Oncology, both on national and international levels. After having worked in a small biotech company focused on Renal Cell Carcinoma, she joined Orphan Europe, a key player in the field of Rare Diseases where she was sequentially responsible for the set-up of our US operations and the global marketing lead for the product portfolio, before joining Pfizer in 2014, coming back to her oncology roots and being responsible for mRCC and our Haematological Franchise. Since 2016, Nicole leads the Rare Disease Business unit in her current role. In 2021 she was selected as Co-Chair of Pfizer’s Diversity & Inclusion Council Europe (DICE).